|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Enhanced dissolution of oxcarbazepine microcrystals using a static mixer process显示文摘 | Douroumis D Fahr A | 2007 | Colloids and surfaces B: B~olnterfaces2007，59，2： | 1 |
| 2 | The application of electrostatic dry powderdeposition technology to coat drug-eluting stents 显示文摘 | Nukala R K Boyapally H Slipper I J Mendham A P Douroumis D | 2010 | Pharmaceutical Research2010，27，1： | 1 |
| 3 | Stable carbamazepine colloidal systems using the cosolvent technique显示文摘 | Fahr A | 2007 | Eur J Pharm Sci2007，30，5： | 1 |
| 4 | Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique显示文摘 | Douroumis D Fahr A | | 0，，02： | 1 |
| 5 | Nano- and micro-particulate for mulations of poorlywater--soluble drugs by using a novel optimized technique 显示文摘 | Douroumis D Fahr A | 2006 | Eur J Pharm Biopharm2006，63，2： | 1 |
| 6 | Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion显示文摘 | Andreas Gryczke Silke Schminke Mohammed Maniruzzaman Julien Beck Dennis Douroumis | 2011 | Colloids and Surfaces B: Biointerfaces2011，，2： | 1 |
| 7 | Investigation of bone reconstruction using an attenuated immunogenicity xenogenic composite scaffold fabricated by 3D printing显示文摘Bone is known to have a natural function to heal itself.However,if the bone damage is beyond a critical degree,intervention such as bone grafting may be imperative.In this work,the fabrication of a novel bone scaffold composed of natural bone components and polycaprolactone(PCL)using 3D printing is put forward.α1,3-galactosyltransferase deficient pigs were used as the donor source of a xenograft.Decellularized porcine bone(DCB)with attenuated immunogenicity was used as the natural component of the scaffold with the aim to promote bone regeneration.The 3D printed DCB-PCL scaffolds combined essential advantages such as uniformity of the interconnected macropores and high porosity and enhanced compressive strength.The biological properties of the DCB-PCL scaffolds were evaluated by studying cell adhesion,viability,alkaline phosphatase activity and osteogenic gene expression of human bone marrow-derived mesenchymal stem cells.The in vitro results demonstrated that the DCB-PCL scaffolds exhibit an enhanced performance in promoting bone differentiation,which is correlated to the DCB content.Furthermore,critical-sized cranial rat defects were used to assess the effect of DCB-PCL scaffolds on bone regeneration in vivo.The results confirm that in comparison with PCL scaffolds,the DCB-PCL scaffolds can significantly improve new bone formation in cranial defects.Thus,the proposed 3D printed DCB-PCL scaffolds emerge as a promising regeneration alternative in the clinical treatment of large bone defects. | Qiongxi Pan Chenyuan Gao Yingying Wang Yili Wang Cong Mao Quan Wang Sophia N.Economidou Dennis Douroumis Feng Wen Lay Poh Tan Huaqiong Li | 2020 | Bio-Design and Manufacturing2020，3，4： | 1 |
| 8 | Nano- and micro particulate formulations of poorly water soluble drugs by using a novel optimized tech- nique显示文摘 | Douroumis D Fahr A | 2006 | European Journal of Pharmaceutics and Biopharma eeutics2006，63，2： | 1 |
| 9 | Stable carbamazepine colloidal systems using the cosolvent technique 显示文摘 | Douroumis D Fahr A | 2007 | Eur J Pharm Sci2007，30，： | 1 |
| 10 | Development and eval- uation of cetirizine HC1 taste-masked oral disintegrating tablets 显示文摘 | Douroumis DD Gryczke A Schminke S | 2011 | AAPS PharmSciTech2011，12，1： | 1 |
| 11 | Enhanced dissolution of Oxcarbazepine microcrystals using a static mixer process 显示文摘 | DOUROUMIS D FAHR A | 2007 | Colloids and Surfaces B: Biointerfaces2007，59，2： | 1 |
| 12 | Development and evaluation of cetirizine HC1 taste-masked oral disinte- grating tablets显示文摘 | Douroumis DD Gryczke A Schminke S | 2011 | AAPS PharmSciTech2011，12，1： | 1 |
| 13 | Practical approaches of taste masking technolo- gies in oral solid Forms 显示文摘 | DOUROUMIS D | 2007 | Expert Opin Drug Deliv2007，4，4： | 1 |
| 14 | Orally disintegrating dosage forms and taste- masking technologies; 2010 显示文摘 | Douroumis D | 2011 | Expert Opin Drug Deliv2011，8，5： | 1 |
| 15 | Stable carbamazepine colloidal systems using the cosolvent technique 显示文摘 | Douroumis D Fahr A | 2007 | Eur J Pharm Sci2007，30，5： | 1 |
| 16 | In vitro release of bovine serum albumin from alginate/HPMC hydrogel beads显示文摘 | NOCHOS A DOUROUMIS D BOUROPOULOS N | 2008 | Carbohydrate Polymers2008，74，3： | 1 |
| 17 | Stable carbamazepine colloidal systems using the cosolvent technique 显示文摘 | Douroumis D Fahr A | 2007 | Eur 3Pharm Sci2007，30，5： | 1 |
| 18 | Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique 显示文摘 | Douroumis D Fahr A | 2006 | Eur J Pharm Biopharm2006，63，2： | 1 |
| 19 | Enhanced dissolution of oxcarbazepine microcrystals using a static mixer process 显示文摘 | Douroumis D Fahr A | 2007 | Colloids Surf B Biointerfaces2007，59，2： | 1 |
| 20 | Enhanced dissolution of Oxcarbazepine microcrystals using a static mixer process 显示文摘 | Douroumis D Fahr A | 2007 | Colloids and Surfaces B: Biointerfaces2007，59，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员